Register
What is the code of conduct for violation of doctor-pharma relationship? |
Medico Legal Corner
eMediNexus Coverage from: 
What is the code of conduct for violation of doctor-pharma relationship?
Dr KK Aggarwal and Ms Ira Gupta,  24 May 2018
Coronavirus Live Count Map India

remove_red_eye 1016 Views
Coronavirus Live Count Map World

#Multispeciality
  Coronavirus FAQ PDF


0 Read Comments                

The same is defined in MCI-211(1)/2009 (Ethics)/55667. In exercise of the powers conferred by Section 33 of the Indian Medical Council Act, 1956 (102 of 1956), the MCI with the previous sanction of the Central Government, hereby makes the following Regulations to amend the “Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002”.

  1. (i) These Regulations may be called the “Indian Medical Council (Professional Conduct Etiquette and Ethics) (Amendment) Regulations, 2009 Part I.”

(ii) They shall come into force from the date of their publication in the Official Gazette.

  1. In the “Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002”, the following additions/modifications/deletions/substitutions, shall be, as indicated therein:
  2. The following clause shall be added after clause 6.7:

6.8: Code of Conduct for doctors and professional association of doctors in their relationship with pharmaceutical and allied health sector industry.

6.8.1: In dealing with pharmaceutical and allied health sector industry, a medical practitioner shall follow and adhere to the stipulations given below:

  1. a) Gifts: A medical practitioner shall not receive any gift from any pharmaceutical or allied healthcare

industry and their sales people or representatives.

  1. b) Travel facilities: A medical practitioner shall not accept any travel facility inside the country or outside, including rail, air, ship, cruise tickets, paid vacations, etc. from any pharmaceutical or allied healthcare industry or their representatives for self and family members for vacation or for attending conferences, seminars, workshops, CME programme, etc. as a delegate.
  2. c) Hospitality: A medical practitioner shall not accept individually any hospitality like hotel

accommodation for self and family members under any pretext.

  1. d) Cash or monetary grants: A medical practitioner shall not receive any cash or monetary grants from any pharmaceutical and allied healthcare industry for individual purpose in individual capacity

under any pretext. Funding for medical research, study, etc. can only be received through approved

institutions by modalities laid down by law/rules/guidelines adopted by such approved institutions,

in a transparent manner. It shall always be fully disclosed.

  1. e) Medical research: A medical practitioner may carry out, participate in, work in research projects

funded by pharmaceutical and allied healthcare industries. A medical practitioner is obliged to know

that the fulfillment of the following items (i) to (vii) will be an imperative for undertaking any research

assignment/project funded by industry for being proper and ethical. Thus, in accepting such a position

a medical practitioner shall:

  1. i) Ensure that the particular research proposal (s) has the due permission from the competent

concerned authorities;

  1. ii) Ensure that such a research project (s) has the clearance of national/state/institutional ethics

committee/bodies;

iii) Ensure that it fulfills all the legal requirements prescribed for medical research;

  1. iv) Ensure that the source and amount of funding is publically disclosed at the beginning itself;
  2. v) Ensure that proper care and facilities are provided to human volunteers, if they are necessary for

the research project (s);

  1. vi) Ensure that undue animal experimentations are not done and when these are necessary they are

done in a scientific and a humane way;

vii) Ensure that while accepting such an assignment a medical practitioner shall have the freedom to

publish the results of the research in the greater interest of the society by inserting such a clause

in the MoU or any other document/agreement for any such assignment.

  1. f) Maintaining professional autonomy: In dealing with pharmaceutical and allied healthcare industry a medical practitioner shall always ensure that there shall never be any compromise either with his/her

own professional autonomy and/or with the autonomy and freedom of the medical institution.

  1. g) Affiliation: A medical practitioner may work for pharmaceutical and allied healthcare industries

in advisory capacities as consultants, as researchers as treating doctors or in any other professional

capacity. In doing so, a medical practitioner shall always:

  1. i) Ensure that his professional integrity and freedom are maintained;
  2. ii) Ensure that patients interest are not compromised in any way;

iii) Ensure that such affiliations are within the law;

  1. iv) Ensure that such affiliation/employments are fully transparent and disclosed.

 

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now